Search

Search Constraints

You searched for: Author/Creator Verschueren, K.

Search Results

2. FRI0329 Impact of Clinical Remission on Physical Function in Patients with Rheumatoid Arthritis Treated with Alx-0061: Post-Hoc Analysis of Phase I/Ii Data. (10th June 2014)

3. OC-0374: Does low-dose TBI improve outcome in patients with early stage low grade NHL? (EORTC 20971-22997). (November 2020)

4. OP0043 Twenty-Four Weeks of Treatment with a Novel Anti-IL-6 Receptor Nanobody® (ALX-0061) Resulted in 84% ACR20 Improvement and 58% DAS28 Remission in a Phase I/Ii Study in RA. (23rd January 2014)